
Sr. Associate Director, PM Strategy – Breast
AstraZeneca
Summary
As Sr. Associate Director, PM Strategy – Breast, you will own tumor-type and biomarker strategy for the Breast portfolio, ensuring every launch is testing-ready, strategically aligned, and built to scale. Reporting to the Director, Precision Medicine Strategy, you will develop precision medicine plans across all assigned brands and indications, anticipate biomarker and testing requirements, and translate complex science into market strategy.
Job description
Working in close partnership with Brand and Indication Teams, Global Diagnostics, Medical Diagnostics, Access, Insights & Analytics, Field Teams, and the Lab Ecosystem & Diagnostic Partnerships team, this individual will serve as the precision medicine partner embedded within each Breast brand and indication team and as the lab subject-matter expert for franchise leadership.
Key Responsibilities
Tumor-Type & Biomarker Strategy
- Serve as the Precision Medicine Strategy lead for the Breast portfolio, developing PM plans across all assigned brands and indications.
- Own biomarker and testing strategy, prioritization of investments, and launch readiness for assigned assets, aligned with global and US brand objectives.
- Recommend priorities and investments that address shared brand needs and maximize patient identification across the portfolio.
- Monitor biomarker testing performance, market dynamics, competitive developments, and diagnostic trends to generate actionable insights.
Launch Readiness & Lab Integration
- Build integrated launch-readiness plans that address testing adoption, patient identification, laboratory preparedness, and stakeholder engagement.
- Inform lab segmentation, KPI selection, and partnership objectives in collaboration with the Lab Ecosystem & Diagnostic Partnerships team, identifying which labs to prioritize for each indication.
- Identify barriers to biomarker testing adoption, diagnostic access, and utilization early, and drive cross-functional resolution.
- Partner with Global Diagnostics and Medical Diagnostics teams to support assay readiness, testing implementation, and market preparation.
Cross-Functional Leadership
- Lead cross-functional precision medicine workstreams involving Brand, Medical, Access, Field Teams, Insights & Analytics, Market Research, and Commercial Excellence partners.
- Influence franchise strategic decisions through data-driven recommendations and customer insights.
- Bring field and lab intelligence into planning decisions and align HQ plans with field priorities.
- Apply the PM Launch Playbook and shared ways of working consistently across tumor types.
Portfolio & Business Planning
- Support annual brand planning, forecasting, and portfolio prioritization processes.
- Assess emerging opportunities and risks related to testing adoption, diagnostic access, and patient identification.
- Share best practices and lessons learned across tumor types to improve organizational effectiveness.
- Coach and develop team members as assigned, including supporting the Associate Director, PM Strategy on cross-tumor initiatives.
Compliance & Governance
- Ensure all activities are conducted in accordance with AstraZeneca policies, Code of Ethics, SOPs, and applicable regulatory requirements.
- Maintain high standards of scientific integrity, compliance, and patient-centered execution.
Leadership Expectations
The successful candidate will demonstrate:
- Strategic thinking and a strong commercial mindset.
- Ability to translate complex science into actionable market strategy.
- Launch excellence with a focus on execution and results.
- Collaboration and stakeholder management across matrixed teams.
- Customer-centric decision making and passion for advancing precision medicine for cancer patients.
Scope of Responsibility
This role is accountable for precision medicine strategy across the Breast portfolio, covering biomarkers including ESR1, HER2, HER2-low/ultralow, Ki-67, and TROP2, and assets potentially including ENHERTU (ultralow), camizestrant (ESR1), CAMBRIA, and other Breast launch opportunities.
Requirements
- Bachelor's degree in Life Sciences, Healthcare, Marketing, Business, or related field
- Minimum of 6 years of pharmaceutical, biotechnology, diagnostics, or healthcare marketing or strategy experience
- At least 2 years of diagnostics, biomarker, precision medicine, or laboratory-focused experience
- Oncology marketing, precision medicine, diagnostics, or pharmaceutical strategy experience
- Experience supporting product launches and commercialization in the US market
- Demonstrated strategic planning and cross-functional leadership, with project management skills
- Proven ability to influence without direct authority in a matrix environment
- Strong analytical, communication, and presentation skills
- MBA, MS, PharmD, PhD, or other advanced degree preferred
- Experience with Breast oncology launches or biomarker-driven assets preferred
- Experience with companion diagnostics, molecular testing, pathology, or lab commercialization preferred
- Knowledge of laboratory workflows, biomarker testing ecosystems, and patient identification strategies preferred
- Experience using data, analytics, and AI-enabled tools to inform strategic decisions preferred
Benefits
- 401(k) Retirement Programs
- Paid Time Off
- Vacation
- Holiday Pay
- Leaves
- Health Insurance
- Dental Coverage
- Vision Coverage
- Short-Term Incentive Bonuses
- Equity-Based Awards
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.